Earnings History Data for BioAtla, Inc. (BCAB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
BioAtla, Inc.
BioAtla Inc. is a clinical-stage biopharmaceutical company. It engages in developing a novel class of antibody-based therapeutics for the treatment of solid tumor cancer. BioAtla Inc. is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-03-2024 | AH | BCAB | BioAtla, Inc. | 115.53 | -0.56 | -0.68 | -0.63 | BioAtla reports Q4 results [3/26/2024 4:03 PM] |
3.47 | 0.46 (15.28%) |
3.01 | 0.0 (0.00%) |
1.24 - 4.07 | 2,139,203 | 420,000 | 26,092 | ||
| 07-11-2023 | AH | BCAB | BioAtla, Inc. | 88.44 | -0.70 | -0.77 | -0.69 | BioAtla reports Q3 results [11/7/2023 4:28 PM] |
1.65 | -0.11 (-6.25%) |
1.80 | 0.04 (2.27%) |
1.24 - 11.73 | 475,598 | 480,000 | 7,637 | ||
| 01-08-2023 | AH | BCAB | BioAtla, Inc. | 137.76 | -0.75 | -0.62 | -0.77 | BioAtla reports Q2 results [8/1/2023 5:07 PM] |
2.98 | 0.10 (3.30%) |
2.88 | 0.0 (0.00%) |
2.23 - 12.15 | 448,811 | 180,000 | 2,441 | ||
| 11-05-2023 | AH | After the close (May 11) |
BCAB | BioAtla, Inc. | 154.72 | -0.58 | -0.66 | -0.65 | BioAtla reports Q1 results [5/11/2023 4:48 PM] |
3.67 | 0.46 (14.33%) |
3.21 | 0.0 (0.00%) |
2.08 - 12.15 | 538,383 | 350,000 | 312 | |
| 23-03-2023 | AH | After the close (Mar 23) |
BCAB | BioAtla, Inc. | 150.01 | -0.63 | -0.74 | -0.63 | BioAtla reports Q4 results [3/23/2023 4:13 PM] |
2.31 | 0.01 (0.43%) |
2.30 | 0.0 (0.00%) |
2.01 - 12.15 | 1,097,750 | 390,000 | 1,787 | |
| 04-11-2022 | AH | 4:05 PM ET (Nov 3) |
BCAB | BioAtla, Inc. | 269.74 | -0.69 | -0.77 | -0.68 | BioAtla reports Q3 results [11/3/2022 4:36 PM] |
8.10 | 0.55 (7.22%) |
7.29 | -0.26 (-3.44%) |
2.01 - 31.02 | 1,668,825 | 1,420,000 | 23,903 | |
| 09-08-2022 | AH | 5:10 PM ET (Aug 9) |
BCAB | BioAtla, Inc. | 142.17 | -0.77 | -0.69 | -0.90 | BioAtla reports Q2 results [8/9/2022 5:14 PM] |
6.76 | 3.15 (87.26%) |
3.74 | 0.0 (0.00%) |
2.01 - 43.61 | 18,882,907 | 180,000 | 1,792 | |
| 05-05-2022 | AH | After the close (May 4) |
BCAB | BioAtla | 130.00 | -0.65 | -0.69 | 0.00 | BioAtla reports Q1 results [5/4/2022 4:31 PM] |
2.38 | -1.70 (-41.79%) |
3.75 | -0.33 (-8.09%) |
2.33 - 51.83 | 2,434,356 | 697,904 | 2,717 | |
| 01-03-2022 | PM | BCAB | BioAtla, Inc. | 244.22 | -0.63 | -0.72 | 0.00 | BioAtla reports Q4 results [3/1/2022 6:20 AM] |
6.42 | -0.06 (-1.00%) |
6.48 | 0.0 (0.00%) |
6.09 - 76.63 | 341,142 | 520,000 | 154,420 | ||
| 13-08-2021 | AH | BCAB | Bioatla, Inc. | 1,393 | -0.90 | -0.56 | 0.00 | BioAtla reports Q2 results [8/13/2021 6:04 PM] |
40.07 | -1.14 (-2.77%) |
41.21 | 0.0 (0.00%) |
27.15 - 76.63 | 144,441 | 200,000 | 282 | ||